Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Entertainment Wire Massachusetts.
Press releases published on May 6, 2025
Candel Therapeutics to Present at Upcoming Investor Conferences
GlobeNewswire
·
May 6, 2025
NEEDHAM, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, …
Majority of Advertisers Report DSP Access Would Unlock More Budget for Retail Media, According to New Koddi Survey
GlobeNewswire
·
May 6, 2025
FORT WORTH, Texas, May 06, 2025 (GLOBE NEWSWIRE) -- Koddi, the leading retail and commerce media technology for enterprises, revealed that the majority of both brands and agencies say that DSP access would encourage them to move more of their non-retail …
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
GlobeNewswire
·
May 6, 2025
BOSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that David …
Avalyn Announces Multiple Presentations on AP01 and AP02 for Pulmonary Fibrosis at the American Thoracic Society 2025 International Conference
GlobeNewswire
·
May 6, 2025
Topline Results from the AP02 (Inhaled Nintedanib) Phase 1 Clinical Trials Among the Company’s Five Poster Presentations 4.5 Year Long-Term Safety and Efficacy Data Supporting AP01 (Inhaled Pirfenidone) from the ATLAS Open-Label Extension Trial to be …
Compass Therapeutics to Participate in Upcoming May Investor Events
GlobeNewswire
·
May 6, 2025
BOSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, today announced that the Company will participate in the …
Cogent Biosciences Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 6, 2025
Three Registration-Directed Top-line Data Readouts Remain on Track in 2025: SUMMIT in NonAdvanced SM expected in July, APEX in Advanced SM expected in second half of the-year and PEAK in GIST expected by end of year Ended 1Q 2025 with $245.7 million in …
Pixel Gun 2 coming to mobile and PC early in 2026
GlobeNewswire
·
May 6, 2025
LIMASSOL, Cyprus, May 06, 2025 (GLOBE NEWSWIRE) -- GDEV Inc. (NASDAQ: GDEV), an international gaming and entertainment company ("GDEV" or the "Company") today announces the development of Pixel Gun 2, a fully cross-platform sequel to its hit franchise …
Sensei Biotherapeutics Reports First Quarter 2025 Financial Results and Updates on Clinical Progress
GlobeNewswire
·
May 6, 2025
- Favorable clinical data in PD-(L)1 resistant patients - - Dose expansion enrollment complete with full data expected by year-end 2025 - - Cash runway into the second quarter of 2026 - BOSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. …
Mersana Therapeutics Announces Strategic Restructuring and Reprioritization Plan Focused on Advancing Emi-Le in Triple-Negative Breast Cancer
GlobeNewswire
·
May 6, 2025
Cost-saving initiatives expected to extend company’s cash runway and support current operating plan commitments into mid-2026 Company to host conference call at 8:00 a.m. ET on May 15 to discuss business updates and first quarter 2025 financial results …
Fractyl Health to Report First Quarter 2025 Financial Results and Provide Business Updates on May 13, 2025, and Will Participate in an Upcoming Investor Conference
GlobeNewswire
·
May 6, 2025
BURLINGTON, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pattern breaking approaches that treat root causes of obesity and type 2 diabetes (T2D), today announced it …
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
GlobeNewswire
·
May 6, 2025
WALTHAM, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will participate in the following May investor conferences: BofA Securities 2025 Healthcare Conference: Fireside chat on Tuesday, …
Beam Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights
GlobeNewswire
·
May 6, 2025
First Patient Dosed in the Phase 1/2 Study of BEAM-301 in Glycogen Storage Disease Type Ia, Beam’s Second Clinical Stage In Vivo Editing Program Updated Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 Accepted for Presentation at the European …
Upstream Bio Reports First Quarter 2025 Financial Results and Accelerates Guidance on All Clinical Programs
GlobeNewswire
·
May 6, 2025
– Top-line data from Phase 2 clinical trial of verekitug in patients with chronic rhinosinusitis with nasal polyps expected in the third quarter of 2025 – – Top-line data from Phase 2 clinical trial of verekitug in patients with severe asthma now expected …
$14M in Jewels Hit Auction Block for $1 Amidst Tariff Turmoil
GlobeNewswire
·
May 6, 2025
LAS VEGAS, May 06, 2025 (GLOBE NEWSWIRE) -- With rising tariffs, inflation, and economic uncertainty shaking global markets, investors are turning to gold and fine jewelry as a safe-haven asset. Now, a $14 million jewelry auction series at Lloyds Auctions …
Best Payday Loans Online For Quick Cash and Fast Approval. New Report Reveals How To Get Fast, Reliable Emergency Cash Today.
GlobeNewswire
·
May 6, 2025
New York, May 06, 2025 (GLOBE NEWSWIRE) -- WhatBest, a trusted platform for independent product and service rankings, has published its new editorial guide on the best payday loans online for quick cash and fast approval here. With economic uncertainty …
TestoPrime Review and Results: A 30 Day Test By WhatBest Reveals Results Of Using TestoPrime For 1 Month.
GlobeNewswire
·
May 6, 2025
New York, May 06, 2025 (GLOBE NEWSWIRE) -- WhatBest, a leading product review and comparison platform, has published a detailed 30-day user review of TestoPrime, a natural testosterone support supplement gaining traction among men looking to boost energy, …
عبد الله عسيري الرئيس التنفيذي لـ"لوسيديا" يضخ دماء جديدة في الهيكل القيادي للشركة
GlobeNewswire
·
May 6, 2025
الرياض، المملكة العربية السعودية , May 06, 2025 (GLOBE NEWSWIRE) -- كشف عبدالله عسيري، المؤسس والرئيس التنفيذي لشركة "لوسيديا" الرائدة في مجال تجربة العملاء المدعومة بالذكاء الاصطناعي، عن تشكيلة قيادية جديدة ستقود دفة الشركة نحو آفاق أرحب من النمو والتوسع …
Lucidya’s CEO Abdullah Asiri Announces Key Appointments As Part of Executive Leadership Team
GlobeNewswire
·
May 6, 2025
RIYADH, Saudi Arabia, May 06, 2025 (GLOBE NEWSWIRE) -- Lucidya’s CEO and founder, Abdullah Asiri, recently announced key appointments to the AI-powered, unified customer experience (CXM) platform executive leadership team. The new leadership appointments …